Login / Signup
Breakthrough treatment choice for Acute Myeloid Leukemia in pediatric and adult patients: Revumenib, an oral selective inhibitor of KMTA2Ar.
Areeba Fareed
Nimrah Inam
Fatima Faraz
Published in:
Rare tumors (2023)
Keyphrases
</>
acute myeloid leukemia
combination therapy
allogeneic hematopoietic stem cell transplantation
decision making
smoking cessation
acute lymphoblastic leukemia